-
Endo Pharmaceuticals NASDAQ:ENDP Endo is a specialty pharmaceutical company committed to helping everyone it serves live their best life through the delivery of quality, life-enhancing therapies. Its decades of proven success come from a global team of passionate employees collaborating to bring the best treatments forward. Together, it boldly transforms insights into treatments benefiting those who need them, when they need them.
Location: | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
0.00
Cash
0.00
Avg Qtr Burn
N/A
Short % of Float
0.00%
Insider Ownership
0.00%
Institutional Own.
0.00%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Approved Quarterly sales | ||
XIAFLEX (injectable CCH (collagenase clostridium histolyticum)) Details Peyronie's disease, Dupuytren's contracture, Adhesive capsulitis | Approved Quarterly sales | |
Collagen clostridium histolyticum (CCH) Details Plantar Fibromatosis | Phase 3 Initiation | |
Collagen clostridium histolyticum (CCH) Details Plantar fasciitis (PFA) | Phase 2 Initiation |